Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Akeso Biopharma Inc (9926 HK)
Watchlist
211
Analysis
Health Care
•
China
Akeso Inc. operates operatesa s a biotech company. The compnay develops treatments and therapies for various types of diseases. Akeso serves cutomers worldwide
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Akeso Biopharma Inc
•
02 Dec 2024 08:55
2025 High Conviction – China Healthcare: Chinese Biotech to Compete on the International Stage
Akeso's investment certainty increases based on promising HARMONi-2 data, leading to potential market value surpassing Innovent and reaching above...
Xinyao (Criss) Wang
Follow
369 Views
Share
bullish
•
Akeso Biopharma Inc
•
14 Oct 2024 08:55
Akeso Biopharma Placement - The Placing Price Is Not Cheap Despite Positive Business Progress
Akeso delivers impressive HARMONi-2 data, which greatly increases the possibility of positive OS. But the market cap already partially reflects...
Xinyao (Criss) Wang
Follow
467 Views
Share
bullish
•
Akeso Biopharma Inc
•
10 Oct 2024 19:38
Akeso Placement - Opportunistic Raise, past Deal Record Has Been Mixed but Relative Size Is Small
Akeso Biopharma Inc (9926 HK) is looking to raise around US$200m from its primary placement. Proceeds from the placement will be used for R&D.
Sumeet Singh
Follow
454 Views
Share
bullish
•
Akeso Biopharma Inc
•
11 Sep 2024 08:55
Akeso Biopharma Inc (9926 HK) - Something Beautiful Is Happening
AK112's HARMONi-2 results show promise, but FDA approval depends on OS. Summit is actually a better investment than Akeso. Investors bet Summit to...
Xinyao (Criss) Wang
Follow
345 Views
Share
bullish
•
Akeso Biopharma Inc
•
03 Sep 2024 18:46
[Akeso Inc. (9926 HK, BUY, TP HK$63) TP Change]: Too Many Positives to Count…Reiterate TOP BUY
Akeso reports better-than-expected financial results, with positive Phase III start for CD-47 mAb (AK117) leading to a raised price target and top...
Blue Lotus Research Institute
Follow
235 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x